Inhalation Anesthetics Market Segments, Growth, and Trends by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Inhalation Anesthetics Market covers analysis by Product ( Sevoflurane, Desflurane, Isoflurane ); Application ( Induction, Maintenance ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Oct 2025
  • Report Code : TIPRE00007625
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Apr 2025

AI overview of Inhalation Anesthetics Market


The Inhalation Anesthetics Market is poised for significant growth, projected to reach a market size of US$ XX million by 2031, with a compound annual growth rate (CAGR) of 4.7% from 2025 to 2031. This growth is driven by an increase in surgical procedures globally and advancements in anesthesia delivery systems. Historical data from 2021 to 2023 indicates a robust foundation for this market, which is further supported by a rising geriatric population. Key trends include a shift towards environment-friendly anesthetic agents and the growing popularity of Sevoflurane, particularly in pediatric and neonatal anesthesia. The Inhalation Anesthetics Market report highlights opportunities for developing low-GWP agents and expanding anesthesia services in rural areas, ensuring a comprehensive analysis of future market dynamics.


The Inhalation Anesthetics Market is expected to register a CAGR of 4.7% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Inhalation Anesthetics Market report covers analysis by Product (Sevoflurane, Desflurane, Isoflurane); Application (Induction, Maintenance), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Inhalation Anesthetics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Inhalation Anesthetics Market Segmentation

Product

  • Sevoflurane
  • Desflurane
  • Isoflurane

Application

  • Induction
  • Maintenance

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Inhalation Anesthetics Market: Strategic Insights

inhalation-anesthetics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Inhalation Anesthetics Market Growth Drivers

  • Growing Surgical Procedures Worldwide: Chronic diseases like cancer, cardiovascular issues, and orthopedic conditions are rising due to factors such as sedentary lifestyles, aging populations, and genetic predispositions. These diseases often require surgical intervention, creating a sustained demand for anesthetics. Inhalation anesthetics are preferred in many cases for their ability to induce and maintain anesthesia quickly and effectively. The increase in elective and emergency surgeries globally, coupled with technological advancements in surgical techniques, has further amplified the market demand.
  • Advancements in Anesthesia Delivery Systems: Modern anesthesia machines are equipped with state-of-the-art features like integrated monitoring, real-time gas analysis, and automated dosing. These innovations ensure the accurate administration of inhalation anesthetics, reducing the risk of overdosage or complications. They also enable better utilization of anesthetic agents, minimizing wastage and cost, which appeals to healthcare facilities aiming for operational efficiency. In August 2023, Mindray launched A Series Anesthesia Systems, improving patient safety and operational efficiency. AnaeSight™ is Mindray's revolutionary solution for combined intravenous-inhalational anesthesia (CIVIA), which integrates anesthesia machines, patient monitors, and pumps to centrally control both intravenous and inhalational anesthetics.
  • Rising Geriatric Population: The global population aged 65 and older is increasing, especially in developed regions like Europe, North America, and parts of Asia. Older adults are more likely to suffer from age-related conditions such as arthritis, cardiovascular disease, and fractures, which often require surgical treatment. In June 2023, Lunan Pharmaceutical Group obtained marketing authorization from the Netherlands Committee for Drug Evaluation for sevoflurane for inhalation. This general anesthetic agent is used for adult and pediatric patients. Approvals are expected in Germany and Spain shortly after that. That would be the second product by Lunan that gains approval in the Netherlands. Inhalation anesthetics are effective in managing anesthesia in this demographic due to their controllable depth of sedation and rapid recovery profiles, minimizing postoperative complications.

Inhalation Anesthetics Market Future Trends

  • Movement to Environment-Friendly Anesthetic Agents: Desflurane and nitrous oxide inhalation agents are linked with greenhouse gas effects due to emissions into the atmosphere. There has been a change toward less impactful environmental agents such as sevoflurane. Anesthetic agents like sevoflurane, along with technology such as closed-circuit anesthesia systems implemented in hospitals and manufacturing, cut anesthetic gas emissions into the atmosphere.
  • Increasing Popularity of Sevoflurane: Among anesthetics, sevoflurane has also been widely accepted for low pungency, rapid induction, and recovery. Pediatric and outpatient procedures require quick recovery of the patient and a safe anesthesia profile, which makes sevoflurane a good alternative. In terms of efficiency, healthcare facilities make sevoflurane in increasing demand.
  • Focus on Pediatric and Neonatal Anesthesia: The anesthesia in children and neonates differs as the latter needs unique physiology-related applications. Companies are creating unique formulation and delivery devices especially to accommodate pediatric needs and sedation efficacy without exposing the young patient to dangers. It has emerged as an upcoming market trend in recent years.

Inhalation Anesthetics Market Opportunities

  • Development of Low-GWP Agents: Sustainability in the environment is now a concern in healthcare. The manufacturers have an opportunity to design anesthetic agents with low GWP and clinical effectiveness. This will align with global sustainability initiatives and address concerns over the environment in the use of inhalation anesthetics.
  • Strategic Collaborations and Partnerships: Partnerships between pharmaceutical companies and healthcare providers can accelerate the adoption of advanced anesthetic solutions. Collaborations often focus on training programs, co-development of technologies, and clinical trials, which facilitate market penetration and establish trust among healthcare professionals.
  • Expansion of Anesthesia Services in Rural Areas: In many developing regions, rural healthcare facilities lack access to advanced anesthesia services. By addressing these gaps, manufacturers can significantly expand their market reach. Affordable and portable anesthesia systems tailored for low-resource settings can further drive growth in these underserved areas.

Inhalation Anesthetics Market Regional Insights

The regional trends and factors influencing the Inhalation Anesthetics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Inhalation Anesthetics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Inhalation Anesthetics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 4.7%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Sevoflurane
  • Desflurane
  • Isoflurane
By Application
  • Induction
  • Maintenance
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • AbbVie Inc.
  • Baxter International
  • Eisai Co., Ltd.
  • Fresenius Kabi AG
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Luman Pharmaceutical Group Co., Ltd

  • Inhalation Anesthetics Market Players Density: Understanding Its Impact on Business Dynamics

    The Inhalation Anesthetics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


    inhalation-anesthetics-market-cagr

    • Get the Inhalation Anesthetics Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Inhalation Anesthetics Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Inhalation Anesthetics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    What are the major driving factors impacting the Inhalation Anesthetics Market?
    The major factors driving the Inhalation Anesthetics Market are Growing Surgical Procedures Worldwide, Advancements in Anesthesia Delivery Systems, and Rising Geriatric Population
    2
    What are the future trends of the Inhalation Anesthetics Market?
    The key future trends of the market are Movement to Environment-Friendly Anesthetic Agents, Increasing Popularity of Sevoflurane, and Focus on Pediatric and Neonatal Anesthesia
    3
    Which are the leading players operating in the Inhalation Anesthetics Market?
    The leading players operating in the Inhalation Anesthetics Market include Abbott, AbbVie Inc., Baxter International, Eisai Co., Ltd., Fresenius Kabi AG, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd., Luman Pharmaceutical Group Co., Ltd.
    4
    What are the deliverable formats of Inhalation Anesthetics Market report?
    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
    5
    What are the options available for the customization of this report?
    Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
    6
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Abbott
    2. AbbVie Inc.
    3. Baxter International
    4. Eisai Co., Ltd.
    5. Fresenius Kabi AG
    6. Halocarbon Products Corporation
    7. Hikma Pharmaceuticals PLC
    8. Jiangsu Hengrui Medicine Co. Ltd.
    9. Luman Pharmaceutical Group Co., Ltd
    10. Piramal Enterprises Limited
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo